Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bode

Showing results (441-450 of 756) with videos related to

Pageof 76
Sort By:
Cancers|July 12, 2025
TOPK Drives IL19-Mediated Crosstalk Between Cancer Cells and Fibroblasts to Promote Solar UV-Induced Skin Damage and CarcinogenesisAsad U Khan, Qiushi Wang, Eunmiri Roh, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Fyn-mediated phosphorylation of Menin disrupts telomere maintenance in stem cellsSouren Paul, Preston M McCourt, Le Thi My Le, et al.
The Journal of Biological Chemistry|July 3, 2010
Role of NEK6 in tumor promoter-induced transformation in JB6 C141 mouse skin epidermal cellsYoung Jin Jeon, Kun Yeong Lee, Yong-Yeon Cho, et al.
Ebiomedicine|February 6, 2018
Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing TetraploidizationYiu To Yeung, Shuying Yin, Bingbing Lu, et al.
Clinical Nephrology|November 5, 2004
Low dialysance of asymmetric dimethylarginine (ADMA)--in vivo and in vitro evidence of significant protein bindingJ T Kielstein, R H Böger, S M Bode-Böger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2010
Circulating angiopoietin-2 levels increase with progress of chronic kidney diseaseSascha David, Philipp Kümpers, Alexander Lukasz, et al.
Cancer Research|September 19, 2007
Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformationKe Yao, Yong-Yeon Cho, H Robert Bergen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2019
Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell CarcinomaFeifei Liu, Xueyin Zu, Xiaomeng Xie, et al.
Toxicology and Applied Pharmacology|July 28, 2009
Synergistic acceleration of thyroid hormone degradation by phenobarbital and the PPAR alpha agonist WY14643 in rat hepatocytesN Wieneke, F Neuschäfer-Rube, L M Bode, et al.
Circulation|April 12, 2000
Is asymmetric dimethylarginine a novel marker of atherosclerosis?R H Böger, S M Bode-Böger, H Matsuoka, et al.
Pageof 76

Showing results (441-450 of 756) with videos related to

Sort By:
Pageof 76
Cancers|July 12, 2025
TOPK Drives IL19-Mediated Crosstalk Between Cancer Cells and Fibroblasts to Promote Solar UV-Induced Skin Damage and CarcinogenesisAsad U Khan, Qiushi Wang, Eunmiri Roh, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Fyn-mediated phosphorylation of Menin disrupts telomere maintenance in stem cellsSouren Paul, Preston M McCourt, Le Thi My Le, et al.
The Journal of Biological Chemistry|July 3, 2010
Role of NEK6 in tumor promoter-induced transformation in JB6 C141 mouse skin epidermal cellsYoung Jin Jeon, Kun Yeong Lee, Yong-Yeon Cho, et al.
Ebiomedicine|February 6, 2018
Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing TetraploidizationYiu To Yeung, Shuying Yin, Bingbing Lu, et al.
Clinical Nephrology|November 5, 2004
Low dialysance of asymmetric dimethylarginine (ADMA)--in vivo and in vitro evidence of significant protein bindingJ T Kielstein, R H Böger, S M Bode-Böger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 25, 2010
Circulating angiopoietin-2 levels increase with progress of chronic kidney diseaseSascha David, Philipp Kümpers, Alexander Lukasz, et al.
Cancer Research|September 19, 2007
Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformationKe Yao, Yong-Yeon Cho, H Robert Bergen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2019
Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell CarcinomaFeifei Liu, Xueyin Zu, Xiaomeng Xie, et al.
Toxicology and Applied Pharmacology|July 28, 2009
Synergistic acceleration of thyroid hormone degradation by phenobarbital and the PPAR alpha agonist WY14643 in rat hepatocytesN Wieneke, F Neuschäfer-Rube, L M Bode, et al.
Circulation|April 12, 2000
Is asymmetric dimethylarginine a novel marker of atherosclerosis?R H Böger, S M Bode-Böger, H Matsuoka, et al.
Pageof 76